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c-Maf belongs to the large Maf family of transcription factors and plays a key role in 
the regulation of cytokine production and differentiation of TH2, TH17, TFH, and Tr1 cells. 
Invariant natural killer T (iNKT) cells can rapidly produce large quantity of TH-related 
cytokines such as IFN-γ, IL-4, and IL-17A upon stimulation by glycolipid antigens, 
such as α-galactosylceramide (α-GalCer). However, the role of c-Maf in iNKT cells and 
iNKT cells-mediated diseases remains poorly understood. In this study, we demonstrate 
that α-GalCer-stimulated iNKT  cells express c-Maf transcript and protein. By using 
c-Maf-deficient fetal liver cell-reconstituted mice, we further show that c-Maf-deficient 
iNKT cells produce less IL-17A than their wild-type counterparts after α-GalCer stimula-
tion. While c-Maf deficiency does not affect the development and activation of iNKT cells, 
c-Maf is essential for the induction of IL-17-producing iNKT (iNKT17) cells by IL-6, TGF-
β, and IL-1β, and the optimal expression of RORγt. Accordingly, c-Maf-deficient iNKT17 
cells lose the ability to recruit neutrophils into the lungs. Taken together, c-Maf is a 
positive regulator for the expression of IL-17A and RORγt in iNKT17 cells. It is a potential 
therapeutic target in iNKT17 cell-mediated inflammatory disease.
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inTrODUcTiOn
Natural killer T (NKT) cells are a subset of lymphocytes that bridge innate and adaptive immunity 
(1). They are special lymphocytes with both NK and T cell lineage markers (2) and are important 
immune cells that contribute to the defense against infectious diseases, allergy, cancer development, 
and autoimmunity (3–5). NKT cells are heterogeneous and can be divided into several subtypes 
based on their CD1d dependence and TCR repertoire (6). The most well-studied NKT cells are the 
CD1d-dependent invariant NKT (iNKT) cells which have a limited repertoire of αβTCR chains, 
allowing them to recognize glycolipid antigens [e.g., α-galactosylceramide (α-GalCer)] presented 
by CD1d molecules expressed by antigen-presenting cells (APCs) (7). Upon activation by α-GalCer, 
iNKT cells rapidly produce a large amount of cytokines, including IFN-γ (TH1 cytokine) and IL-4 
and IL-13 (TH2 cytokine). In addition, recent studies have demonstrated that iNKT cells can also 
secret TH17-related cytokines, such as IL-17A, IL-17F, IL-21, and IL-22 (8–10). Furthermore, non-
committed iNKT cells can be induced to produce IL-17A when activated in the presence of IL-6, 
TGF-β, and IL-1β, thereby triggering airway neutrophilic inflammation (11).
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c-Maf belongs to the large Maf family of transcription fac-
tors, which contain a basic leucine zipper domain. c-Maf is 
expressed at a high level in TH2 cells and is critical for inducing 
IL-4 expression and TH2 commitment (12, 13). Recent studies 
have demonstrated that c-Maf is also expressed in other immune 
cells, including TH17, TFH, and LPS-activated macrophages, and 
regulates the expression of IL-22, IL-21, and IL-10 (14–17). 
Previous study also demonstrated the capacity of c-Maf to bind 
to both Il17a and Il17f promoters in TH17 cells (18). Furthermore, 
c-Maf interacted with Sox5 and cooperatively induced TH17 
cell differentiation via induction of RORγt (19). These finding 
strongly suggest that c-Maf plays a direct role in IL-17A produc-
tion in TH17 cells. Recently, it is reported that c-Maf is one of 
the downstream target genes of the transcription factor PLZF 
in iNKT  cells, as c-Maf expression is compromised in PLZF-
deficient iNKT and γδNKT cells. Moreover, ectopic expression 
of c-Maf is sufficient to rescue IL-4 and IL-10 production by 
PLZF-deficient iNKT cells (20). However, the role of c-Maf in 
iNKT cells is not well known.
In this study, we used a genetic approach to demonstrate that 
c-Maf is expressed in α-GalCer-activated iNKT cells. We further 
show that c-Maf is required for the optimal expression of RORγt 
and IL-17, but not IFN-γ or IL-4, in iNKT cells and is essential for 
their ability to induce airway neutrophilic inflammation in vivo.
MaTerials anD MeThODs
Mice and cells
The 6- to 8-week-old female C57BL/6J mice from the Laboratory 
Animal Center of National Taiwan University College of 
Medicine were used as the source of naive CD4+ T  cells and 
iNKT  cells. All animals were housed under specific pathogen-
free conditions. This study was carried out in strict accordance 
with the recommendations in the Guide for the Care and Use of 
Laboratory Animals of the National Institutes of Health (NIH). 
The protocol was approved by the Institutional Animal Care 
and Use Committee of National Taiwan University College of 
Medicine (Permit Number: 20140426). Water and food were pro-
vided sufficiently daily. All mice were sacrificed by CO2. Primary 
CD4+ T cells and iNKT cells cultured in complete RPMI 1640 
medium (containing 10% FBS, 1 mM sodium pyruvate, 2 mM 
l-glutamine, 100 µM MEM non-essential amino acids, 10 mM 
HEPES, 5.5 ×  10−5 M β-mercaptoethanol, 100 U/ml penicillin, 
and 100 µg/ml streptomycin).
generation of c-Maf-Deficient 
reconstituted Mice
To generate the c-Maf-deficient reconstituted mice, the donor 
cells for hematopoietic reconstitution were collected from 
fetal livers of c-Maf-deficient fetuses (C57BL/6J-CD45.1) 
on embryonic day 14.5 (E14.5) and were transplanted into 
C57BL/6J-CD45.2 recipient mice, which were previously 
exposed to a single dose of X-ray irradiation (7 Gy) by tail vein 
injection. After 2  months for reconstitution of hematopoietic 
system, more than 90% hematopoietic cells were CD45.1+ con-
firmed by flow cytometry.
Flow cytometry and cell sorting
Mouse CD1d tetramers coupled to APC and loaded with PBS-57 
(an iNKT cell ligand analog to α-GalCer) were provided by the 
NIH Tetramer Core Facility. Fluorochrome-labeled monoclonal 
antibodies (mAbs) specific to mouse CD45.1 (A20), CD45.2 
(104), TCRβ (H57-597), CD4 (RM4-5), NK1.1 (PK136), Gr-1 
(RB6-8C5), CD11b (M1/70), CD69 (H1.2F3), IFN-γ (XMG1.2), 
IL-4 (11B11), and IL-17A (TC11-18H10.1) were all purchased 
from BioLegend. c-Maf mAb (sym0F1) was purchased from eBio-
science. For intracellular cytokine staining, cells were incubated 
with PMA (50 ng/ml), ionomycin (500 ng/ml), and brefeldin A 
(10 µg/ml; Sigma) for 3 h. After preincubation with unconjugated 
anti-CD16/32 (2.4G2; BioLegend) mAb, cells were stained for 
surface antigen and then fixed and permeabilized using the IC 
fixation buffer and permeabilization buffer (eBioscience) fol-
lowed by incubation with anti-cytokine or isotype control Abs. 
FACS data were acquired by BD LSRFortessa (BD Biosciences) 
and analyzed with FlowJo software. For cell sorting, murine naive 
CD4+CD62Lhi T cells and CD1d/PBS-57+TCRβ+ iNKT cells were 
sorted by FACSAria IIIu (BD Biosciences).
In Vitro Th cell Differentiation
Naive CD4+ T cells (CD4+CD62Lhi) were prepared from spleens 
and peripheral lymph nodes (LNs) of 5- to 6-week-old wild-type 
(WT) female C57BL/6J mice, and stained with PE-CD4 (RM4-5) 
and FITC-CD62L (MEL-14) Abs (eBioscience), and purified by 
cell sorter (FACS Aria IIIu; BD Biosciences). Naive CD4+ T cells 
were seeded at 1 × 106 cells/ml in complete RPMI 1640 medium 
and stimulated with plate-bound anti-CD3 (1  µg/ml; 2C11) 
mAb under TH0, TH1 (1 ng/ml of IL-12 and 10 µg/ml of anti-
IL-4 mAb), TH2 (10 ng/ml of IL-4 and 10 µg/ml of anti-IFN-γ 
mAb), or TH17-skewing (20 ng/ml of IL-6, 2.5 ng/ml of TGF-β, 
10 µg/ml of anti-IFN-γ, and 10 µg/ml of anti-IL-4) medium in 
the presence of γ-irradiated splenocytes (2,000 rad) as APCs for 
5  days. Under TH0, TH1, and TH2-skewing conditions, human 
IL-2 (100 U/ml) was supplied with fresh medium daily; however, 
for TH17-skewing condition, human IL-2 (50 U/ml) was added 
on day 0 only. The skewed TH cells were restimulated on anti-
CD3-coated plate (1 µg/ml) for 24 h on day 5.
In Vivo stimulation of inKT cells
α-Galactosylceramide (2 µg in 100 µl PBS) or vehicle (DMSO in 
100 µl PBS) was injected into the tail veins of WT or c-Maf knock-
out (KO) reconstituted mice. Splenocytes were collected 2 h after 
injection and cultured in complete RPMI 1640 medium (T cell 
culture medium; RPMI 1640 with 10% FBS, HEPES, penicillin 
and streptomycin, sodium pyruvate, nonessential amino acids, 
l-glutamine, and β-mercaptoethanol) in the presence of brefel-
din A (10 µg/ml) for 2 h, and intracellular cytokine staining for 
IFN-γ, IL-4, IL-17A in iNKT cells was performed.
In Vitro induction of il-17-Producing  
inKT cells
Splenocytes from WT or c-Maf KO reconstituted mice were pre-
incubated on the anti-IgM/IgA/Ig light chain κ antibody-coated 
plates (10  µg/each Ab; BioLegend) to deplete B  cells at room 
FigUre 1 | α-Galactosylceramide (α-GalCer)-stimulated invariant natural killer T (iNKT) cells express c-Maf. (a) TH0, TH1, TH2, and TH17 cells were re-stimulated with 
plate-bound anti-CD3 monoclonal antibody (mAb) for 24 h. Purified CD1d/PBS-57+TCRβ+ iNKT cells were cultured in vitro for 3 days. The transcript levels of c-Maf 
were determined by quantitative PCR and normalized against β-actin expression in each sample (n = 3). (B) α-GalCer or PBS was injected into the tail veins of WT 
C57BL/6J mice. Splenocytes and lymph node (LN) cells of the injected mice were collected 2 h later and subjected first to surface staining with PBS-57-loaded 
CD1d tetramer, anti-TCR-β mAb, and then intracellular staining for c-Maf. Representative FACS plots are shown. NS, not significant, determined by unpaired t-test, 
two-tailed (n = 3).
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temperature for 45  min. After B  cell depletion, WT or c-Maf 
KO splenocytes were stimulated with α-GalCer (100 ng/ml) to 
expand iNKT population for 5  days. CD45.1+ CD45.2− CD1d/
PBS-57+ TCRβ+ iNKT cells were purified by cell sorter (FACSAria 
IIIu; BD Biosciences). Purified WT or c-Maf KO iNKT cells were 
stimulated with plate-bound anti-CD3 (2 µg/ml) and anti-CD28 
(5 µg/ml) in the presence of IL-6 (20 ng/ml), TGF-β (1 ng/ml), 
IL-1β (10 ng/ml; PeproTech), anti-IFN-γ (10 µg/ml), and anti-
IL-4 (10  µg/ml) mAbs on 96-well plates (50,000  cells/well) for 
4 days to induce IL-17-producing iNKT cells.
Quantitative real-time Pcr
Total RNA was extracted with TRIzol Reagent (Invitrogen) 
according to the manufacturer’s instructions, and the cDNA 
was generated using SuperScript III Reverse Transcriptase 
(Invitrogen) or MMLV High Performance Reverse Transcriptase 
(epicentre). Standard SYBR Green real-time PCR was performed 
using and a IQ5 PCR detection system (Bio-Rad) or PikoReal 
Real-Time PCR system (Thermo Scientific). Relative expression 
of the target gene was normalized to β-actin and calculated as 
2−(Ct target − Ct β-actin). The Ct represents the threshold cycle for each 
target or reference gene determined by Bio-Rad iQ5 or Thermo 
PikoReal Software 2.2. The relative target gene expression was 
calculated by using the 2−ΔΔCt method.
In Vivo airway neutrophilia experiments
Wild-type C57BL/6J (6- to 8-week old) mice were anesthetized 
with Escain® (Isoflurane) and then injected with 50,000 WT or 
c-Maf-deficient IL-17-producing iNKT  cells via intratracheal 
route. Two days postinjection, the mice were sacrificed and 
the trachea cannulated, the airways were lavaged five times 
with 1  ml ice-old PBS and the bronchoalveolar lavage (BAL) 
collected.
statistical analysis
Statistical analyses were performed with unpaired, two-tailed 
Student’s t-tests. A value of P < 0.05 was considered statistically 
significant.
resUlTs
α-galcer-activated inKT cells express 
c-Maf Transcript and Protein
c-Maf is expressed in TH2, TH17, TFH, and LPS-activated mac-
rophages (12–17). However, the expression of c-Maf in iNKT cells 
has yet to be characterized. To examine the expression of c-Maf 
in iNKT cells, CD1d/PBS-57+TCRβ+ cells were sorted from the 
splenocytes of WT C57BL/6J mice and cultured with complete 
RPMI 1640 medium for 3 days in vitro. Quantitative PCR results 
showed that iNKT  cells expressed a level of c-Maf transcript 
that was much higher than that of anti-CD3-restimulated TH0 
and TH1 cells, but comparable to that of anti-CD3-restimulated 
TH2 and TH17 cells (Figure  1A). To confirm the expression of 
c-Maf in vivo, WT mice were treated with α-GalCer and their 
splenocytes and LN cells were subjected first to surface staining 
with PBS-57-loaded CD1d tetramer and anti-TCRβ mAb, and 
then intracellular staining for c-Maf and indicated cytokines. 
There was a higher percentage of c-Maf-expressing iNKT cells 
in the peripheral LNs (67.0 ± 1.6%) than spleens (33.5 ± 3.2%) 
in vehicle (PBS)-treated mice. However, α-GalCer stimulation 
did not affect the percentages of c-Maf-expressing iNKT cells in 
either spleens (38.9 ± 0.7%) or LNs (67.9 ± 1.6%) (Figure 1B). 
Interestingly, c-Maf is expressed in IFN-γ, IL-4 or IL-17-
producing iNKT  cells (data not shown). Taken together, these 
results demonstrate that α-GalCer-activated iNKT cells express 
c-Maf mRNA and protein.
FigUre 2 | Invariant natural killer T (iNKT) cells from c-Maf knockout (KO)-reconstituted mice do not produce IL-17A upon α-galactosylceramide (α-GalCer) 
stimulation. (a) Total splenocytes were isolated from wild-type (WT) or c-Maf KO reconstituted mice and stained with PBS-57-loaded CD1d tetramer and 
monoclonal antibodies (mAbs) specific for TCR-β, CD4, and NK1.1. The percentages of iNKT cells among splenocytes and the percentage of the four subsets of 
iNKT cells (defined by NK1.1 and CD4) among total iNKT cells are determined by flow cytometry. Representative FACS plots are shown. NS, not significant, 
determined by unpaired t-test, two-tailed (n = 3). (B) The splenocytes were also stimulated with α-GalCer (100 ng/ml) for 4 days in vitro. The levels of IFN-γ, IL-4, 
IL-17A, and IL-10 in the culture supernatants were measured by ELISA. NS, not significant, *P < 0.05 determined by unpaired t-test, two-tailed (n = 3).
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c-Maf Positively regulates il-17a 
Production in α-galcer-activated inKT 
cells
c-Maf KO mice are embryonic lethal due to anemia (21). We 
therefore reconstituted WT C57BL/6J mice with fetal liver cells 
from c-Maf KO embryos. The percentage of the iNKT population 
among splenocytes was comparable between WT and c-Maf KO 
reconstituted mice, indicating that c-Maf deficiency does not 
affect the development and homeostasis of iNKT  cells in the 
spleen. Furthermore, the distribution of major iNKT subsets 
based on the expression of CD4 and NK1.1 was not affected by 
c-Maf deficiency (Figure 2A).
To investigate the role of c-Maf in iNKT cells, we stimulated 
WT and c-Maf KO splenocytes with α-GalCer in  vitro and 
quantified their production of cytokines by ELISA. We found 
that splenocytes from reconstituted c-Maf KO mice produced 
significantly less IL-17A compared to WT splenocytes. By 
contrast, the levels of IFN-γ, IL-4, and IL-10 were comparable 
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between WT and c-Maf KO splenocytes (Figure 2B). Since only 
iNKT cells respond to α-GalCer, our results indicate that c-Maf is 
a positive regulator for IL-17A production in α-GalCer-activated 
iNKT cells.
To address the role of c-Maf in regulating IL-17A production 
by iNKT  cells in  vivo, WT and c-Maf KO reconstituted mice 
were given α-GalCer intravenously. iNKT cells in the spleen and 
peripheral LNs were analyzed with intracellular cytokine staining. 
While c-Maf deficiency did not affect the activation state (CD69 
expression) of splenic and LN iNKT cells, it markedly reduced 
their expression of IL-17A (Figure  3). These results together 
demonstrate that c-Maf positively regulates IL-17A production 
in α-GalCer-stimulated iNKT cells both in vitro and in vivo.
c-Maf-Deficiency Deters the Polarization 
of inKT17 cells In Vitro
Invariant NKT  cells can be induced to produce IL-17A when 
activated in the presence of IL-6, TGF-β, and IL-1β (11). To 
determine whether c-Maf is also critical for such polarization of 
iNKT17 cells, we expanded WT and c-Maf KO splenic and LN 
iNKT cells in vitro with α-GalCer, then stimulated the expanded 
iNKT cells with anti-CD3/anti-CD28 in the presence or absence 
of IL-6, TGF-β, and IL-1β. The cells were re-stimulated with PMA/
ionomycin prior to intracellular cytokine staining. Expectedly, 
IL-6, TGF-β, and IL-1β induced the polarization of iNKT17 
cells with about 10% of those cells stained positive for IL-17A. 
By contrast, only approximately 1% of c-Maf KO iNKT17 cells 
produced IL-17A (Figure  4A). This difference was even more 
striking in LN iNKT17 cells. About 50% of LN WT iNKT17 cells 
were stained positive for IL-17A, whereas only 2% of c-Maf KO 
LN iNKT17 cells expressed IL-17A (Figure  4B). The marked 
impairment in the production of IL-17 by c-Maf KO iNKT17 
cells was also confirmed with ELISA (Figures 4A,B).
Invariant NKT cells also express other cytokines, including 
IL-17F, IL-21, and IL-22, which are subject to regulation by 
c-Maf in TH17 cells. We found that the transcript levels of IL-17F 
and IL-21 were also notably reduced in c-Maf KO iNKT17 cells, 
suggesting that dependence on c-Maf is not unique to IL-17A 
in iNKT17 cells (Figure 4C). A recent study showed that c-Maf 
interacted with Sox5 and cooperatively induced TH17 cell differ-
entiation via induction of RORγt (19). We found that the tran-
script level of RORγt, but not Sox5, was also markedly reduced 
in c-Maf KO iNKT17 cells, indicating that the mechanism of 
action of c-Maf in iNKT17 cells is similar to that in TH17 cells 
(Figure 4C).
c-Maf KO inKT17 cells lose the ability to 
recruit neutrophils to the lungs
Invariant NKT17 cells are known to drive neutrophilic airway 
inflammation (11). To examine the impact of c-Maf deficiency 
on iNKT17 cell-mediated airway neutrophilia, we injected 
in vitro generated WT or c-Maf KO iNKT17 cells into the tra-
chea of naive C57BL/6J mice. The mice were sacrificed 2 days 
later and the presence of neutrophils (Gr-1HiCD11bHi) in BAL 
was examined with flow cytometric analysis (Figure  5A). In 
agreement with published data, intra-tracheal injection of 
WT iNKT17 cells leads to a marked increase in the numbers 
of neutrophils in BAL (Figures 5B,C). By contrast, c-Maf KO 
iNKT17 cells were completely unable to cause the infiltration of 
neutrophils to airways.
DiscUssiOn
Transcription factor c-Maf is critical for IL-4 production by 
TH2 cells and critical for TH2 commitment (12, 13). It also plays 
important roles in the regulation of cytokine production in TH17, 
TFH, Tr1 cells, and macrophages (14–17, 22). In addition, a previ-
ous study has demonstrated that c-Maf is induced by PLZF and 
this PLZF/c-Maf axis positively regulates IL-4 and IL-10 produc-
tion by iNKT  cells (20). However, whether c-Maf can regulate 
other cytokine gene(s) or functions in iNKT  cells is not fully 
understood. Moreover, the roles of c-Maf in iNKT cell-mediated 
inflammation have not yet been addressed. Our data have estab-
lished a critical role of c-Maf in promoting the expression of IL-17 
by iNKT cells. This function of c-Maf is very likely mediated indi-
rectly through the induction of RORγt. Hence, the knowledge 
gained from this study will bring important insight into the role 
of glycolipid antigen-c-Maf-IL-17A axis in iNKT cells.
The level of c-Maf transcript in unstimulated iNKT  cells 
is comparable to that in anti-CD3-restimulated TH2 or TH17 
cells and the percentages of c-Maf-expressing iNKT  cells are 
unchanged after α-GalCer stimulation. These observations 
strongly suggest that the c-Maf expression is maintained at a basal 
level in iNKT cells, allowing them to rapidly respond to glycolipid 
antigens and produce a cytokine surge.
To further investigate the role of c-Maf in iNKT cells, we use 
CD45.1+ c-Maf-deficient fetal liver cells to reconstitute the hemat-
opoietic system of WT C57B6/J mice. c-Maf plays a critical role in 
erythropoiesis that accompanies erythroblastic island formation 
in the fetal liver (21). Therefore, the number of fetal liver cells 
is significantly lower in c-Maf−/− embryos than in WT embryos. 
Moreover, the frequency of c-Maf homozygous KO embryos 
is usually lower than WT or heterozygous embryos within the 
same pregnancy. It is time-consuming; at least two months per 
one reconstitution is needed to generate a sufficient number of 
c-Maf-deficient reconstituted mice to conduct the experiments. 
Thus, c-Maf conditional KO mice (23) could be employed in the 
future studies.
We found that the percentage of splenic iNKT cells was lower 
in WT reconstituted mice (~0.6%) compared to un-manipulated 
WT C57BL6/J mice (~1%). The reconstituted iNKT cells were also 
less robust in producing cytokines (data not shown). Nevertheless, 
c-Maf deficiency did not affect the development and homeostasis 
of iNKT cells in peripheral lymphoid organs. However, we can-
not exclude the possibility that c-Maf deficiency might affect the 
development of iNKT cells in the central lymphoid organ. It will 
be of great interest to examine whether c-Maf is involved in the 
development of iNKT cells in the thymus once c-Maf conditional 
KO mice are available.
Our data are the first to show that c-Maf is a positive regulator 
for IL-17A production in iNKT cells. As c-Maf is also expressed 
in iNKT cells that produce type 1 and type 2, but not IL-17, it is 
essential but not sufficient to drive IL-17 expression alone. c-Maf 
FigUre 3 | c-Maf deficiency impairs the production of IL-17A by invariant natural killer T (iNKT) from α-galactosylceramide (α-GalCer)-treated mice. α-GalCer or 
PBS was injected into the tail veins of wild-type (WT) or c-Maf knockout (KO) reconstituted mice. Splenocytes (a) and lymph node (LN) cells (B) of the injected mice 
were collected 2 h later and subjected first to surface staining with PBS-57-loaded CD1d tetramer, anti-TCR-β and CD69 monoclonal antibodies (mAbs), and then 
intracellular staining for indicated cytokines. Representative FACS plots are shown. NS, not significant, *P < 0.05; ***P < 0.001 determined by unpaired t-test, 
two-tailed (n = 3 in PBS-treated group; n = 6 in α-GalCer-treated group).
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FigUre 4 | Splenic and lymph node (LN) c-Maf knockout (KO) invariant natural killer T (iNKT) 17 cells express less IL-17A than wild-type (WT) counterparts. Splenic 
(a) and LN (B) iNKT cells from WT or c-Maf KO reconstituted mice expanded in vitro with α-galactosylceramide (α-GalCer) for 5 days, sorted, and stimulated with 
anti-CD3/anti-CD28 plus IL-6/TGF-β/IL-1β (iNKT17-skewing conditions). The cells were restimulated with PMA/ionomycin, and the expression of indicated cytokines 
and transcription factors was examined with intracellular cytokine staining and ELISA (a,B), or quantitative PCR (c). Representative FACS plots and cumulative 
results are shown. NS, not significant, *P < 0.05; **P < 0.01; ***P < 0.001 determined by unpaired t-test, two-tailed (n = 3). (c) iNKT17-related mRNA profiles were 
measured by quantitative PCR. The expression of mRNA in each sample was normalized against the level of β-actin. The data shown are from three independent 
experiments, and the values from WT are arbitrarily set as 1.0. UD, undetectable.
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is known to directly bind to the MARE site(s) on the promoter 
of target genes and positively or negatively regulate target gene 
expression. Ciofani et al. have clearly demonstrated that c-Maf 
can binds to both Il17a and Il17f promoters in TH17 cells (18). 
In our study, we found that c-Maf-deficient iNKT17 cells also 
expressed less Il17a, Il17f, and Il21, suggesting a global defect 
in iNKT17 transcriptional program. Similar to TH17 cells, the 
master transcription factor of iNKT17 cells is also RORγt (24). 
A recent study showed that c-Maf interacted with Sox5 and 
cooperatively induced TH17 cell differentiation via induction of 
RORγt (19). In agreement with this report, the level of RORγt 
was also reduced in c-Maf KO iNKT17 cells, suggesting that the 
mechanism of action of c-Maf in iNKT17 cells is similar to that 
in TH17 cells. It will be informative to examine whether c-Maf can 
bind to the promoters of Il17a, Il17f, and Rorc in iNKT17 cells 
by chromatin immunoprecipitation (ChIP). However, we were 
unable to generate sufficient numbers of c-Maf KO iNKT cells 
for ChIP despite several attempts.
Our results indicate that c-Maf is not required for IL-4 pro-
duction in iNKT cells, a finding not consistent with the previous 
studies demonstrating that c-Maf is required for IL-4 production 
in CD4+ NKT or iNKT cells (13, 20). The discrepancy could be 
due to differences in genetic backgrounds (C57BL/6J vs. BALB/c) 
or approaches (hematopoietic reconstitution vs. germline KO). 
An alternative explanation is that there could be redundant 
positive regulator(s) downstream of PLZF for IL-4 expression 
FigUre 5 | c-Maf knockout (KO) Invariant natural killer T (iNKT) 17 cells lose the ability to recruit neutrophils to the lungs. Fifty thousand wild-type (WT) or c-Maf KO 
iNKT17 cells, or PBS were injected into the trachea of naive C57BL/6J mice (six mice per group), which were sacrificed 2 days later. Neutrophils (Gr-1HiCD11bHi) in 
bronchoalveolar lavage were identified by FACS. Representative FACS plots are shown in (a). The percentage (B) and absolute number (c) of neutrophils are also 
shown. **P < 0.01 determined by unpaired t-test, two-tailed (n = 6).
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in iNKT  cells. These positive regulators could compensate the 
IL-4 expression in c-Maf-deficient iNKT cells. Recently, Andris 
et al. demonstrated that c-Maf promotes the differentiation of TFH 
cells and showed that c-Maf-deficient TH2 or TH17 cells still can 
produce IL-4 or IL-17, respectively (25). These findings suggest 
that c-Maf plays an essential role in IL-17A expression in iNKT17 
cells. It is still unclear whether c-Maf can interact with PLZF. 
Thus, it will be informative to examine the interaction between 
c-Maf and PLZF in iNKT17 cells.
Several studies have demonstrated that iNKT  cells are 
an important source of TH17 type cytokines during airway 
inflammation. In mice, Michel et  al  have firstly identified an 
IL-17-producing NK1.1− iNKT  cell population that is more 
frequent in the lung and responsible for neutrophil recruit-
ment after α-GalCer administration (9). Another study shows 
that iNKT  cells are required for airway inflammation induced 
by environmental antigens existing in house dust extracts 
(HDEs). Lung iNKT  cells produced not only TH2 cytokines 
but also TH1 cytokines and IL-17A after challenge with OVA/
HDE. The IL-17A production was especially prominent in lung 
CD4− iNKT cells. In addition, there was a synergistic activation 
between iNKT  cells and conventional CD44high memory CD4 
T cells in OVA/HDE-vaccinated mice (26). It is also reported that 
polyinosinic-polycytidylic acid [poly(I:C)] plus α-GalCer could 
promote the IL-17A production by CD4−NK1.1− iNKT  cells. 
Their intratracheal administration resulted in increased airway 
hyper-reactivity, neutrophilia in BAL and airway inflammation, 
suggesting that airway inflammation could be further aggravated 
by viral induced iNKT17 cells (27). Therefore, suppressing 
IL-17A production by iNKT17 through targeting c-Maf can be 
therapeutic in airway inflammation.
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